| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Kiran Satchandra Divi B. Pharm., M.Pharm CEO | MSE Exchange | INE361B01024 ISIN |
| India Country | 9,741 Employees | 24 Jul 2026 Last Dividend | 30 Jul 2009 Last Split | - IPO Date |
Divi's Laboratories Limited is a prominent player in the pharmaceutical industry, specializing in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals. With a strong presence in India, North America, Asia, and Europe, the company has carved a niche for itself on the international stage. Besides its core offerings, Divi's Laboratories extends its expertise to custom synthesis and contract manufacturing services of APIs and intermediates, catering to a diverse client base. Initially established as Divi's Research Center in 1990, the company underwent a rebranding in 1994 to become Divi's Laboratories Limited. Headquartered in Hyderabad, India, it has grown substantially over the years, driven by a commitment to quality and innovation in the pharmaceutical sector.
Divi's Laboratories Limited offers a wide array of products and services catering to the needs of the pharmaceutical, food, dietary supplement, and feed manufacturers industries. These offerings underscore the company's versatility and expertise in the field.